SCHEMBL20186988

SCHEMBL20186988

CCCc1cc(N)cc(C)c1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.41
USP2 O75604 1/20 0.39
HTT P42858 2/20 0.38
LMNA P02545 3/20 0.38
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
ALDH1A1 P00352 6/20 0.37
MAPT P10636 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HPGD P15428 6/20 0.35
GAA P10253 5/20 0.35
GLA P06280 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 1/20 0.34
BCAT2 O15382 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20186996 0.85 KDM4E (0.43) KDM4EUSP2HTTLMNARECQL
SCHEMBL524571 0.78 KDM4E (0.54) KDM4EUSP2HTTLMNARECQL
SCHEMBL13981267 0.77 ALDH1A1 (0.36) KDM4EHTTALDH1A1MAPTHSD17B10
SCHEMBL5161523 0.75 ALDH1A1 (0.37) KDM4EHTTALDH1A1MAPTHPGD
SCHEMBL6250872 0.72 KDM4E (0.65) KDM4EHTTMAPK1RECQLALDH1A1
SCHEMBL9800893 0.72 GABRA1 (0.38) KDM4ELMNAALDH1A1MAPTMEN1
SCHEMBL27666619 0.71 KDM4E (0.47) KDM4EUSP2HTTLMNARECQL
SCHEMBL27878369 0.71 KDM4E (0.44) KDM4EUSP2LMNAMAPK1RECQL
SCHEMBL16956630 0.70 CYP1A2 (0.44) KDM4EUSP2HTTLMNAALDH1A1
SCHEMBL29739381 0.69 KDM4E (0.46) KDM4EUSP2HTTRECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10905120-B2 ABA receptor agonists that modulate transpiration THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-02-02 US disclosed
US-20180146666-A1 ABA RECEPTOR AGONISTS THAT MODULATE TRANSPIRATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10905120-B2 ABA receptor agonists that modulate transpiration ADORA2A, ADORA1, AAK1 KDM4E 4352/4885USP2 1480/4885HTT 2920/4885
US-20180146666-A1 ABA RECEPTOR AGONISTS THAT MODULATE TRANSPIRATION ADORA2A, ADORA1, AAK1 KDM4E 4352/4885USP2 1480/4885HTT 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.